MN Health Collaborative Press Release
Post-Operative Opioid Prescribing
The MN Health Collaborative announced they are currently developing an innovative approach to prescribing opioids for post-operative pain. Read the full press release on our MN Health Collaborative page.
Hypertension Diagnosis and Treatment
2018 ICSI Commentary
This commentary affirms key parts of the newly released hypertension guideline; outlining and addressing important criticisms, presenting challenges with operations and management, and offering key takeaways to share with patients.
A New Generation of Collaboration: Read about ICSI's year of transition, renewed interest and excitement for collaboration.
E-cigarettes Evidence Brief
Developed by the Healthy Lifestyles work group, this brief examines the safety of e-cigarettes as well as their use as a tobacco cessation tool.
MN Health Collaborative
The MN Health Collaborative is a powerful example of Minnesota’s healthcare community’s commitment and ability to collaborate - even while being competitors - to better serve our patients, families, and communities.
With ICSI serving as its backbone organization, the MN Health Collaborative includes physicians and other representatives from major healthcare organizations working together to address major health topics affecting Minnesota communities today including opioid misuse and addiction as well as system improvements to address broader mental health care needs.
Reducing Opioid Use and Improving Pain Management
MN Health Collaborative partners are committed to reducing opioid prescribing and overdose deaths, and improving care for people experiencing pain and addiction. Initial efforts focus on nonsurgical and surgical prescribing practices.
Working group members are developing an innovative approach to prescribing opioids for post-operative pain. The new approach addresses the unique needs of patients based on their past health histories, current diagnoses, and required surgical and post-operative treatment needs.
Changing current post-operative prescription standards is a critical step to ensure that patients do not receive more than the required number of pills needed for pain management as overprescribing opioids may lead to side effects and potential dependence for some individuals. Surplus opioid medications also increase the risk of these drugs being diverted from intended use and distributed illegally within the community.
Change in ICSI Leadership
Please join us in thanking Craig Acomb, MS, for his outstanding leadership. Craig has stepped down from his role as ICSI’s CEO effective July 1st due to a disability. When he was named CEO of the Institute for Clinical Systems Improvement (ICSI) in 2016, he brought a wealth of experience and knowledge about health care practice, policy and finance in our community.
While at ICSI he has served as Interim President and Chief Operating Officer where he oversaw successful efforts to reduce hospital readmissions, to improve care for patients with co-existing mental and physical health conditions and to strengthen ICSI as an important collaborative in Minnesota. Before coming to ICSI, he served in leadership positions at the Minnesota Department of Health including Assistant Commissioner, Chief Operating Officer and Chief Financial Officer where he oversaw the budget during the creation of the Minnesota landmark legislation that created the Statewide Health Improvement Program (SHIP).
As CEO of ICSI, Craig’s legacy also includes establishing collaboration to improve care in areas that present major challenges in our community: addressing the opioid epidemic by creating community standards around appropriate use and improving care for patients with chronic pain and mental health conditions. We are grateful for his passion and leadership to improve care for our community through collaboration.
David Abelson, MD and Claire Neely, MD will continue to provide leadership in their roles as President and Chief Medical Officer until a successor is named.
Paula Santrach, MD, Chair of the Board of Directors, ICSI
David Abelson, MD, President, ICSI